InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (INM) — Form SCHEDULE 13G: Ownership over 5% (passive)
About this filing
InMed Pharmaceuticals Inc. (INM) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Nov 13, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More INM filings
- SC 13G
Filed Nov 13, 2026
- SC 13D
Filed Nov 12, 2026
- 4
Filed Nov 12, 2026
- 4
Filed Nov 12, 2026
- 4
Filed Nov 12, 2026
- 4
Filed Nov 12, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.